Cell-Based Immunotherapy Market 2027 By Therapy, Indication | The Insight Partners

Cell-Based Immunotherapy Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Therapy (Autologous Cellular Immunotherapy, Chimeric Antigen Receptor (CAR) T-Cell Therapy, Dendritic Cell-based Vaccine Therapy); Indication (B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Others)

Report Code: TIPRE00015536 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Covid
MARKET INTRODUCTION

Cell-based Immunotherapy is the alternative to replacing cancer treatment with chemotherapy. The human body's stem cells have the ability to heal a host of diseases. The specialized cell will replenish the stem cells of the human body. This is the key fact that stem cells are used in Cell-Based Immunotherapy for the treatment of a different type of cancer. Cell-Based Immunotherapy uses totipotent stem cells. These cells can form extra placental or embryonic cells to cure cancer. The process to transplant the Cell-Based Immunotherapy in the body. During the Cell-Based Immunotherapy, stem cells generate the highly specific T-cells that target the tumor cells by forming the antigen-antibody bond. Though Cell-Based Immunotherapy uses the T-cell, hence it is also referred to as T-cell therapy.

MARKET DYNAMICS

The Cell-Based Immunotherapy market is expected to grow significantly in the coming years, due to rising prevalence of cancer. Moreover, increasing health care expenditure anticipated to influence the end-user of Cell-Based Immunotherapy.

MARKET SCOPE

The "Cell-Based Immunotherapy Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Cell-Based Immunotherapy market with detailed market segmentation by therapy and primary indication. The Cell-Based Immunotherapy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Cell-Based Immunotherapy market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Cell-Based Immunotherapy market is segmented on the basis of by therapy and primary indication. Based on therapy , the market is segmented into Autologous Cellular Immunotherapy, Chimeric Antigen Receptor (CAR) T-Cell Therapy, Dendritic Cell-based Vaccine Therapy. On the basis of Indication, the market is categorized as B-cell Malignancies, prostate cancer, renal cell carcinoma, liver cancer, others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Cell-Based Immunotherapy market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Cell-Based Immunotherapy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Cell-Based Immunotherapy market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Cell-Based Immunotherapy market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Cell-Based Immunotherapy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Cell-Based Immunotherapy market are anticipated to have lucrative growth opportunities in the future with the rising demand for Cell-Based Immunotherapy in the global market. Below mentioned is the list of few companies engaged in the Cell-Based Immunotherapy market.

The report also includes the profiles of key players in Cell-Based Immunotherapy market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   AbbVie Inc.
  •   Genentech USA, Inc.
  •   Amgen Inc
  •   Bayer AG
  •   Boehringer Ingelheim International GmbH.
  •   Eli Lilly and Company
  •   GlaxoSmithKline plc.
  •   Novartis AG
  •   Pfizer Inc
  •   Bio-Rad Laboratories, Inc

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cell-Based Immunotherapy Market - By Therapy
1.3.2 Cell-Based Immunotherapy Market - By Indication
1.3.3 Cell-Based Immunotherapy Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CELL-BASED IMMUNOTHERAPY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CELL-BASED IMMUNOTHERAPY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CELL-BASED IMMUNOTHERAPY MARKET - GLOBAL MARKET ANALYSIS
6.1. CELL-BASED IMMUNOTHERAPY - GLOBAL MARKET OVERVIEW
6.2. CELL-BASED IMMUNOTHERAPY - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. CELL-BASED IMMUNOTHERAPY MARKET - REVENUE AND FORECASTS TO 2027 - THERAPY
7.1. OVERVIEW
7.2. THERAPY MARKET FORECASTS AND ANALYSIS
7.3. AUTOLOGOUS CELLULAR IMMUNOTHERAPY
7.3.1. Overview
7.3.2. Autologous Cellular Immunotherapy Market Forecast and Analysis
7.4. CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY
7.4.1. Overview
7.4.2. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast and Analysis
7.5. DENDRITIC CELL-BASED VACCINE THERAPY
7.5.1. Overview
7.5.2. Dendritic Cell-based Vaccine Therapy Market Forecast and Analysis
8. CELL-BASED IMMUNOTHERAPY MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. B-CELL MALIGNANCIES
8.3.1. Overview
8.3.2. B-cell Malignancies Market Forecast and Analysis
8.4. PROSTATE CANCER
8.4.1. Overview
8.4.2. Prostate Cancer Market Forecast and Analysis
8.5. RENAL CELL CARCINOMA
8.5.1. Overview
8.5.2. Renal Cell Carcinoma Market Forecast and Analysis
8.6. LIVER CANCER
8.6.1. Overview
8.6.2. Liver Cancer Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. CELL-BASED IMMUNOTHERAPY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Cell-Based Immunotherapy Market Overview
9.1.2 North America Cell-Based Immunotherapy Market Forecasts and Analysis
9.1.3 North America Cell-Based Immunotherapy Market Forecasts and Analysis - By Therapy
9.1.4 North America Cell-Based Immunotherapy Market Forecasts and Analysis - By Indication
9.1.5 North America Cell-Based Immunotherapy Market Forecasts and Analysis - By Countries
9.1.5.1 United States Cell-Based Immunotherapy Market
9.1.5.1.1 United States Cell-Based Immunotherapy Market by Therapy
9.1.5.1.2 United States Cell-Based Immunotherapy Market by Indication
9.1.5.2 Canada Cell-Based Immunotherapy Market
9.1.5.2.1 Canada Cell-Based Immunotherapy Market by Therapy
9.1.5.2.2 Canada Cell-Based Immunotherapy Market by Indication
9.1.5.3 Mexico Cell-Based Immunotherapy Market
9.1.5.3.1 Mexico Cell-Based Immunotherapy Market by Therapy
9.1.5.3.2 Mexico Cell-Based Immunotherapy Market by Indication
9.2. EUROPE
9.2.1 Europe Cell-Based Immunotherapy Market Overview
9.2.2 Europe Cell-Based Immunotherapy Market Forecasts and Analysis
9.2.3 Europe Cell-Based Immunotherapy Market Forecasts and Analysis - By Therapy
9.2.4 Europe Cell-Based Immunotherapy Market Forecasts and Analysis - By Indication
9.2.5 Europe Cell-Based Immunotherapy Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Cell-Based Immunotherapy Market
9.2.5.1.1 Germany Cell-Based Immunotherapy Market by Therapy
9.2.5.1.2 Germany Cell-Based Immunotherapy Market by Indication
9.2.5.2 France Cell-Based Immunotherapy Market
9.2.5.2.1 France Cell-Based Immunotherapy Market by Therapy
9.2.5.2.2 France Cell-Based Immunotherapy Market by Indication
9.2.5.3 Italy Cell-Based Immunotherapy Market
9.2.5.3.1 Italy Cell-Based Immunotherapy Market by Therapy
9.2.5.3.2 Italy Cell-Based Immunotherapy Market by Indication
9.2.5.4 Spain Cell-Based Immunotherapy Market
9.2.5.4.1 Spain Cell-Based Immunotherapy Market by Therapy
9.2.5.4.2 Spain Cell-Based Immunotherapy Market by Indication
9.2.5.5 United Kingdom Cell-Based Immunotherapy Market
9.2.5.5.1 United Kingdom Cell-Based Immunotherapy Market by Therapy
9.2.5.5.2 United Kingdom Cell-Based Immunotherapy Market by Indication
9.2.5.6 Rest of Europe Cell-Based Immunotherapy Market
9.2.5.6.1 Rest of Europe Cell-Based Immunotherapy Market by Therapy
9.2.5.6.2 Rest of Europe Cell-Based Immunotherapy Market by Indication
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Cell-Based Immunotherapy Market Overview
9.3.2 Asia-Pacific Cell-Based Immunotherapy Market Forecasts and Analysis
9.3.3 Asia-Pacific Cell-Based Immunotherapy Market Forecasts and Analysis - By Therapy
9.3.4 Asia-Pacific Cell-Based Immunotherapy Market Forecasts and Analysis - By Indication
9.3.5 Asia-Pacific Cell-Based Immunotherapy Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Cell-Based Immunotherapy Market
9.3.5.1.1 Australia Cell-Based Immunotherapy Market by Therapy
9.3.5.1.2 Australia Cell-Based Immunotherapy Market by Indication
9.3.5.2 China Cell-Based Immunotherapy Market
9.3.5.2.1 China Cell-Based Immunotherapy Market by Therapy
9.3.5.2.2 China Cell-Based Immunotherapy Market by Indication
9.3.5.3 India Cell-Based Immunotherapy Market
9.3.5.3.1 India Cell-Based Immunotherapy Market by Therapy
9.3.5.3.2 India Cell-Based Immunotherapy Market by Indication
9.3.5.4 Japan Cell-Based Immunotherapy Market
9.3.5.4.1 Japan Cell-Based Immunotherapy Market by Therapy
9.3.5.4.2 Japan Cell-Based Immunotherapy Market by Indication
9.3.5.5 South Korea Cell-Based Immunotherapy Market
9.3.5.5.1 South Korea Cell-Based Immunotherapy Market by Therapy
9.3.5.5.2 South Korea Cell-Based Immunotherapy Market by Indication
9.3.5.6 Rest of Asia-Pacific Cell-Based Immunotherapy Market
9.3.5.6.1 Rest of Asia-Pacific Cell-Based Immunotherapy Market by Therapy
9.3.5.6.2 Rest of Asia-Pacific Cell-Based Immunotherapy Market by Indication
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Cell-Based Immunotherapy Market Overview
9.4.2 Middle East and Africa Cell-Based Immunotherapy Market Forecasts and Analysis
9.4.3 Middle East and Africa Cell-Based Immunotherapy Market Forecasts and Analysis - By Therapy
9.4.4 Middle East and Africa Cell-Based Immunotherapy Market Forecasts and Analysis - By Indication
9.4.5 Middle East and Africa Cell-Based Immunotherapy Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Cell-Based Immunotherapy Market
9.4.5.1.1 South Africa Cell-Based Immunotherapy Market by Therapy
9.4.5.1.2 South Africa Cell-Based Immunotherapy Market by Indication
9.4.5.2 Saudi Arabia Cell-Based Immunotherapy Market
9.4.5.2.1 Saudi Arabia Cell-Based Immunotherapy Market by Therapy
9.4.5.2.2 Saudi Arabia Cell-Based Immunotherapy Market by Indication
9.4.5.3 U.A.E Cell-Based Immunotherapy Market
9.4.5.3.1 U.A.E Cell-Based Immunotherapy Market by Therapy
9.4.5.3.2 U.A.E Cell-Based Immunotherapy Market by Indication
9.4.5.4 Rest of Middle East and Africa Cell-Based Immunotherapy Market
9.4.5.4.1 Rest of Middle East and Africa Cell-Based Immunotherapy Market by Therapy
9.4.5.4.2 Rest of Middle East and Africa Cell-Based Immunotherapy Market by Indication
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Cell-Based Immunotherapy Market Overview
9.5.2 South and Central America Cell-Based Immunotherapy Market Forecasts and Analysis
9.5.3 South and Central America Cell-Based Immunotherapy Market Forecasts and Analysis - By Therapy
9.5.4 South and Central America Cell-Based Immunotherapy Market Forecasts and Analysis - By Indication
9.5.5 South and Central America Cell-Based Immunotherapy Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Cell-Based Immunotherapy Market
9.5.5.1.1 Brazil Cell-Based Immunotherapy Market by Therapy
9.5.5.1.2 Brazil Cell-Based Immunotherapy Market by Indication
9.5.5.2 Argentina Cell-Based Immunotherapy Market
9.5.5.2.1 Argentina Cell-Based Immunotherapy Market by Therapy
9.5.5.2.2 Argentina Cell-Based Immunotherapy Market by Indication
9.5.5.3 Rest of South and Central America Cell-Based Immunotherapy Market
9.5.5.3.1 Rest of South and Central America Cell-Based Immunotherapy Market by Therapy
9.5.5.3.2 Rest of South and Central America Cell-Based Immunotherapy Market by Indication
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CELL-BASED IMMUNOTHERAPY MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CELL-BASED IMMUNOTHERAPY MARKET, KEY COMPANY PROFILES
12.1. ABBVIE INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. GENENTECH USA, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. AMGEN INC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BAYER AG
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BOEHRINGER INGELHEIM INTERNATIONAL GMBH.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ELI LILLY AND COMPANY
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GLAXOSMITHKLINE PLC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NOVARTIS AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PFIZER INC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BIO-RAD LABORATORIES, INC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. AbbVie Inc.
2. Genentech USA, Inc.
3. Amgen Inc
4. Bayer AG
5. Boehringer Ingelheim International GmbH.
6. Eli Lilly and Company
7. GlaxoSmithKline plc.
8. Novartis AG
9. Pfizer Inc
10. Bio-Rad Laboratories, Inc
TIPRE00015536
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking